BioArctic: AHEAD 3-45 design, notes from the AAIC20 conference
Redeye attended the biomarkers and drug development themes at the digital Alzheimer's Association International Conference (AAIC) and got updates on the clinical studies of AD antibody drug candidates, and on BAN2401 in particular.